Effect of an Educational Intervention on the Management of Ventilator-Associated Pneumonia

被引:0
|
作者
Kanji, Zahra [1 ]
Gill, Sandeep [1 ]
Boldt, Michael [2 ]
Mainra, Rajesh [2 ]
Van Wieren, Barb [1 ]
机构
[1] Lions Gate Hosp, Pharm Dept, 231 East 15th St, N Vancouver, BC V7L 2L7, Canada
[2] Lions Gate Hosp, Dept Med, N Vancouver, BC, Canada
来源
CANADIAN JOURNAL OF HOSPITAL PHARMACY | 2008年 / 61卷 / 04期
关键词
ventilator-associated pneumonia; guidelines; educational intervention;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The publication of guidelines for the management of ventilator-associated pneumonia prompted an evaluation of management of this condition in the intensive care unit (ICU) of a community acute care hospital. Objectives: To evaluate the management of ventilator-associated pneumonia before and after an educational intervention for physicians and to determine the pathogens responsible for this condition among patients in this ICU. Methods: The management of ventilator-associated pneumonia was reviewed, and compliance with published guidelines and with clinically appropriate therapy (in terms of subsequent culture results or local practice) was evaluated for the 7 months before and the 6 months after the 1-week educational intervention. Results: A total of 42 episodes of ventilator-associated pneumonia, which occurred in 37 patients, were evaluated. After the educational intervention, the following changes in end points were observed: appropriate selection of empiric antibiotic therapy according to guidelines increased from 35% of episodes before to 59% of episodes after the intervention (p = 0.11), whereas the selection of empiric therapy subsequently deemed to be clinically appropriate increased from 45% to 77% (p = 0.032); appropriate dosing according to guidelines increased from 20% to 33% (p = 0.33), whereas clinically appropriate dosing increased from 70% to 95% (p = 0.027); appropriate route of therapy according to the guidelines increased from 75% to 82% (p = 0.59) but there was no change in clinically appropriate route of therapy (100% in both phases); timeliness of therapy increased from 85% to 91% (p = 0.56), de-escalation (narrowing of empiric therapy on the basis of culture results) increased from 60% to 100% (p = 0.11), and appropriate duration of therapy decreased from 79% to 55% (p = 0.11). Conclusions: Clinically appropriate selection and dosing of antibiotics for ventilator-associated pneumonia improved after the educational intervention for physicians. The availability of local microbiological data was valuable in guiding empiric antibiotic selection.
引用
收藏
页码:256 / 263
页数:8
相关论文
共 50 条
  • [21] Ventilator-associated pneumonia
    Torres, A
    Carlet, J
    Bouza, E
    Brun-Buisson, C
    Chastre, J
    Ewig, S
    Fagon, JY
    Marquette, CH
    Muñoz, P
    Niederman, MS
    Papazian, L
    Rello, J
    Rouby, JJ
    Van Saene, H
    Welte, T
    EUROPEAN RESPIRATORY JOURNAL, 2001, 17 (05) : 1034 - 1045
  • [22] Ventilator-associated pneumonia
    不详
    CRITICAL CARE NURSE, 2008, 28 (03) : 83 - 85
  • [23] VENTILATOR-ASSOCIATED PNEUMONIA
    MEHTAR, S
    CURRENT OPINION IN INFECTIOUS DISEASES, 1995, 8 (04) : 283 - 286
  • [24] Ventilator-associated pneumonia
    Visnegarwala, F
    Iyer, NG
    Hamill, RJ
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1998, 10 (03) : 191 - 205
  • [25] Ventilator-associated pneumonia
    Akça, O
    LANCET, 2000, 356 (9246): : 2011 - 2011
  • [26] Ventilator-associated pneumonia
    Shaw, MJ
    CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (03) : 236 - 241
  • [27] Ventilator-Associated Pneumonia
    Chant, Clarence
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2006, 59 : 42 - 43
  • [28] Ventilator-associated pneumonia
    不详
    RESPIROLOGY, 2009, 14 : S51 - S58
  • [29] Targeted antibiotic management of ventilator-associated pneumonia
    Fagon, J. -Y.
    Rello, J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 : 17 - 22
  • [30] Advances in the prevention and management of ventilator-associated pneumonia
    Bouza, Emilio
    Burillo, Almudena
    CURRENT OPINION IN INFECTIOUS DISEASES, 2009, 22 (04) : 345 - 351